Diagnosis and treatment of disorders of glucose metabolism and obesity in pediatric age have significantly changed in recent years. The evolution of technologies for the management and the monitoring in type 1 diabetes, the progress in genetic testing for the detection of rare diseases causing diabetes, hyperinsulinism and obesity, the availability of new therapies, the attention to secondary diabetes in Cystic Fibrosis and onco-hematological disease, and to the quality of life of patients affected by chronic diseases, have changed the diagnostic and therapeutic approach of endocrinologists and diabetologists.
Scientific publications do not always consider that pediatric management is different from that of adults. Consensus guidelines or statements are frequently lacking information about rare conditions affecting glucose metabolism and obesity, particularly in pediatric age. Treating pediatric obesity often does not lead to success. There is much discussion about which is the most efficient approach. Recently the literature has reported a correlation between the degree of obesity of children and the quality of life of parents. Is there a higher chance of success in treating the obese child if working on the quality of life of the family? The literature gives growing attention on the diagnosis and treatment of secondary diabetes related to pathologies such as Cystic Fibrosis, onco-hematological diseases, etc. What is the correct diagnostic-therapeutic approach to secondary diabetes in children? Do we need to worry about pediatric cardiovascular diabetic complications?
This Research Topic welcomes manuscripts focusing on the diagnosis and management of diabetes, hyperinsulinism, and obesity in children and adolescents
Special attention will be given to these topics:
• Technologies in type 1 diabetes in pediatric age
• Rare genetic diseases causing diabetes in the pediatric age
• Congenital Hyperinsulinism
• Insulin resistance and obesity in children and adolescents
• Treatment of prediabetes and type 2 diabetes in pediatric age.
• Quality of life in children and adolescents with diabetes
• Quality of life in children and adolescents with obesity
• Secondary diabetes
• Cardiovascular complications in pediatric diabetes
Diagnosis and treatment of disorders of glucose metabolism and obesity in pediatric age have significantly changed in recent years. The evolution of technologies for the management and the monitoring in type 1 diabetes, the progress in genetic testing for the detection of rare diseases causing diabetes, hyperinsulinism and obesity, the availability of new therapies, the attention to secondary diabetes in Cystic Fibrosis and onco-hematological disease, and to the quality of life of patients affected by chronic diseases, have changed the diagnostic and therapeutic approach of endocrinologists and diabetologists.
Scientific publications do not always consider that pediatric management is different from that of adults. Consensus guidelines or statements are frequently lacking information about rare conditions affecting glucose metabolism and obesity, particularly in pediatric age. Treating pediatric obesity often does not lead to success. There is much discussion about which is the most efficient approach. Recently the literature has reported a correlation between the degree of obesity of children and the quality of life of parents. Is there a higher chance of success in treating the obese child if working on the quality of life of the family? The literature gives growing attention on the diagnosis and treatment of secondary diabetes related to pathologies such as Cystic Fibrosis, onco-hematological diseases, etc. What is the correct diagnostic-therapeutic approach to secondary diabetes in children? Do we need to worry about pediatric cardiovascular diabetic complications?
This Research Topic welcomes manuscripts focusing on the diagnosis and management of diabetes, hyperinsulinism, and obesity in children and adolescents
Special attention will be given to these topics:
• Technologies in type 1 diabetes in pediatric age
• Rare genetic diseases causing diabetes in the pediatric age
• Congenital Hyperinsulinism
• Insulin resistance and obesity in children and adolescents
• Treatment of prediabetes and type 2 diabetes in pediatric age.
• Quality of life in children and adolescents with diabetes
• Quality of life in children and adolescents with obesity
• Secondary diabetes
• Cardiovascular complications in pediatric diabetes
